{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T13:42:09Z","timestamp":1770471729953,"version":"3.49.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Syst"],"DOI":"10.1007\/s10916-025-02233-9","type":"journal-article","created":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T07:00:40Z","timestamp":1754636440000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Integrating mHealth Innovations into Decentralized Oncology Trials"],"prefix":"10.1007","volume":"49","author":[{"given":"Fatma Nur","family":"Cicin","sequence":"first","affiliation":[]},{"given":"Irfan","family":"Cicin","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,8,8]]},"reference":[{"issue":"3","key":"2233_CR1","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2196\/14360","volume":"21","author":"GR Signorelli","year":"2019","unstructured":"Signorelli GR, Lehocki F, Mora Fern\u00e1ndez M, et al. Connected health as an enabler of cancer patient support. J Med Internet Res. 2019;21(3):56\u201363. doi:https:\/\/doi.org\/10.2196\/14360","journal-title":"J Med Internet Res"},{"issue":"2","key":"2233_CR2","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.jro.2021.00129","volume":"34","author":"DJ Lu","year":"2021","unstructured":"Lu DJ, Girgis M, David JM, et al. Evaluation of mobile health applications to track patient-reported outcomes for oncology patients: a systematic review. J Radiat Oncol. 2021;34(2):120\u2013134. doi:https:\/\/doi.org\/10.1016\/j.jro.2021.00129","journal-title":"J Radiat Oncol"},{"key":"2233_CR3","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41746-019-0206-x","volume":"3","author":"SP Rowland","year":"2020","unstructured":"Rowland, S.P., Fitzgerald, J.E., Holme, T. et al. What is the clinical value of mHealth for patients?. npj Digit. Med. 3, 4 (2020). https:\/\/doi.org\/10.1038\/s41746-019-0206-x","journal-title":"npj Digit. Med."},{"issue":"6711","key":"2233_CR4","doi-asserted-by":"publisher","first-page":"eadq4994","DOI":"10.1126\/science.adq4994","volume":"385","author":"G Jean-Louis","year":"2024","unstructured":"Jean-Louis G, Seixas AA. The value of decentralized clinical trials: Inclusion, accessibility, and innovation. Science. 2024;385(6711): eadq4994. doi: https:\/\/doi.org\/10.1126\/science.adq4994.","journal-title":"Science"},{"issue":"33","key":"2233_CR5","doi-asserted-by":"publisher","first-page":"3986","DOI":"10.1200\/JCO.24.00961","volume":"42","author":"R Thota","year":"2024","unstructured":"Thota R, Hurley PA, Miller TM, Bruinooge SS, Lipset C, Harvey RD, Black LJ, Dinsdale A, Merrill JK, Pollastro T, Prindiville SA, Rizvi MA, Sherwood S, Nowakowski GS. Improving Access to Patient-Focused, Decentralized Clinical Trials Requires Streamlined Regulatory Requirements: An ASCO Research Statement. J Clin Oncol. 2024;42(33):3986\u20133995. doi: https:\/\/doi.org\/10.1200\/JCO.24.00961. Epub 2024 Jul 30.","journal-title":"J Clin Oncol"},{"issue":"7","key":"2233_CR6","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1002\/cpt.3009","volume":"114","author":"AM Burden","year":"2023","unstructured":"Burden AM, Singh P, Natanegara F. Design and Execution of Sustainable Decentralized Clinical Trials. Clin Pharmacol Ther. 2023;114(7):400\u2013412. doi:https:\/\/doi.org\/10.1002\/cpt.3009","journal-title":"Clin Pharmacol Ther"},{"key":"2233_CR7","doi-asserted-by":"publisher","first-page":"903188","DOI":"10.3389\/fmed.2022.903188","volume":"9","author":"T Sato","year":"2022","unstructured":"Sato T, Ishimaru H, Takata T, Sasaki H, Shikano M. Application of Internet of Medical\/Health Things to Decentralized Clinical Trials: Development Status and Regulatory Considerations. Front Med (Lausanne). 2022;9:903188. doi: https:\/\/doi.org\/10.3389\/fmed.2022.903188.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"2233_CR8","doi-asserted-by":"publisher","first-page":"e093374","DOI":"10.1136\/bmjopen-2024-093374","volume":"15","author":"Y Xia","year":"2025","unstructured":"Xia Y, Guan X, Shi Z, Luo Y, He P. Remote symptom monitoring with patient-reported outcomes and nudges during lung cancer immunotherapy in China (PRO-NET): protocol for a randomised controlled trial. BMJ Open. 2025;15(1):e093374. doi: https:\/\/doi.org\/10.1136\/bmjopen-2024-093374.","journal-title":"BMJ Open"},{"key":"2233_CR9","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","volume":"4","author":"C Baethge","year":"2019","unstructured":"Baethge, C., Goldbeck-Wood, S. & Mertens, S. SANRA\u2014a scale for the quality assessment of narrative review articles. Res Integr Peer Rev 4, 5 (2019). https:\/\/doi.org\/10.1186\/s41073-019-0064-8","journal-title":"Res Integr Peer Rev"},{"issue":"4","key":"2233_CR10","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3322\/caac.21660","volume":"70","author":"F Bray","year":"2020","unstructured":"Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2020;70(4):313\u2013320. doi:https:\/\/doi.org\/10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"2233_CR11","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1200\/JCO.21.00776","volume":"40","author":"R Harrison","year":"2022","unstructured":"Harrison R, Abebe R, Kim S, et al. Accelerating cancer drug development: The role of biomarkers and companion diagnostics. J Clin Oncol. 2022;40(2):145\u2013155. doi:https:\/\/doi.org\/10.1200\/JCO.21.00776","journal-title":"J Clin Oncol"},{"issue":"3","key":"2233_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1634\/theoncologist.2024.03.10","volume":"29","author":"ES Kim","year":"2024","unstructured":"Kim ES, Uhm JE, Lee JM, et al. Overcoming barriers in oncology trials: The evolving role of digital technology. Oncologist. 2024;29(3):173\u2013180. doi:https:\/\/doi.org\/10.1634\/theoncologist.2024.03.10","journal-title":"Oncologist"},{"issue":"5","key":"2233_CR13","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.7759\/cureus.12345","volume":"14","author":"K Allison","year":"2022","unstructured":"Allison K, Patel D, Kaur R. Assessing multiple factors affecting minority participation in clinical trials: Development of the clinical trials participation barriers survey. Cureus. 2022;14(5):1231\u20131240. doi:https:\/\/doi.org\/10.7759\/cureus.12345.","journal-title":"Cureus"},{"key":"2233_CR14","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1200\/EDBK_156686","volume":"35","author":"JM Unger","year":"2016","unstructured":"Unger JM, Cook E, Tai E, Bleyer A. The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies. Am Soc Clin Oncol Educ Book. 2016;35:185\u201398. doi: https:\/\/doi.org\/10.1200\/EDBK_156686.","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2233_CR15","unstructured":"ASPE. Examination of clinical trial costs and barriers in drug development. Available from: https:\/\/aspe.hhs.gov\/reports\/examination-clinical-trial-costs-barriers-drug-development-0"},{"issue":"5","key":"2233_CR16","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1007\/s43441-024-00667-w","volume":"58","author":"ZP Smith","year":"2024","unstructured":"Smith ZP, DiMasi JA, Getz KA. New Estimates on the Cost of a Delay Day in Drug Development. Ther Innov Regul Sci. 2024;58(5):855\u2013862. doi: https:\/\/doi.org\/10.1007\/s43441-024-00667-w.","journal-title":"Ther Innov Regul Sci"},{"issue":"5","key":"2233_CR17","doi-asserted-by":"publisher","first-page":"491","DOI":"10.4155\/cli.14.139","volume":"5","author":"O Johnson","year":"2015","unstructured":"Johnson O. An evidence-based approach to conducting clinical trial feasibility assessments. Clin Investig. 2015;5(5):491\u2013499.","journal-title":"Clin Investig"},{"key":"2233_CR18","doi-asserted-by":"publisher","first-page":"100590","DOI":"10.1016\/j.conctc.2020.100590","volume":"19","author":"H Moseson","year":"2020","unstructured":"Moseson H, Kumar S, Juusola JL. Comparison of study samples recruited with virtual versus traditional recruitment methods. Contemp Clin Trials Commun. 2020;19:100590. doi: https:\/\/doi.org\/10.1016\/j.conctc.2020.100590.","journal-title":"Contemp Clin Trials Commun"},{"issue":"10","key":"2233_CR19","doi-asserted-by":"publisher","first-page":"9205","DOI":"10.3390\/curroncol30100665","volume":"30","author":"EM Lee","year":"2023","unstructured":"Lee EM, Jim\u00e9nez-Fonseca P, Gal\u00e1n-Moral R, Coca-Membribes S, Fern\u00e1ndez-Montes A, Sorribes E, Garc\u00eda-Torralba E, Punt\u00ed-Brun L, Gil-Raga M, Cano-Cano J, Calderon C. Toxicities and Quality of Life during Cancer Treatment in Advanced Solid Tumors. Curr Oncol. 2023;30(10):9205\u20139216. doi: https:\/\/doi.org\/10.3390\/curroncol30100665","journal-title":"Curr Oncol"},{"issue":"6","key":"2233_CR20","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/j.annonc.2024.03.006","volume":"35","author":"I Pourmir","year":"2024","unstructured":"Pourmir I, Nebbache R, Champiat S, Lambotte O; Cancer Immunotherapy Adverse Events Working Group. Reporting and analysis of immunotherapy trials adverse events: What is going wrong, how to do better? Ann Oncol. 2024;35(6):569\u2013570. doi:https:\/\/doi.org\/10.1016\/j.annonc.2024.03.006","journal-title":"Ann Oncol"},{"key":"2233_CR21","doi-asserted-by":"publisher","unstructured":"Joseph M Unger, Riha Vaidya, Dawn L Hershman, Lori M Minasian, Mark E Fleury, Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial Participation, JNCI: Journal of the National Cancer Institute, Volume 111, Issue 3, March 2019, Pages 245\u2013255, https:\/\/doi.org\/10.1093\/jnci\/djy221","DOI":"10.1093\/jnci\/djy221"},{"key":"2233_CR22","doi-asserted-by":"publisher","unstructured":"Karen M. Winkfield et al. Addressing Financial Barriers to Patient participation in Clinical Trials: ASCO Policy Statement. JCO 36, 3331\u20133339(2018). DOI:https:\/\/doi.org\/10.1200\/JCO.18.01132","DOI":"10.1200\/JCO.18.01132"},{"issue":"3","key":"2233_CR23","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.apjon.2021.03.001","volume":"8","author":"JH Tsai","year":"2021","unstructured":"Tsai JH, Yin SC, Chen CF. Withdrawal reasons in oncology clinical trials: A systematic review. Asian Pac J Oncol Nurs. 2021;8(3):198\u2013204. doi:https:\/\/doi.org\/10.1016\/j.apjon.2021.03.001","journal-title":"Asian Pac J Oncol Nurs"},{"issue":"4","key":"2233_CR24","doi-asserted-by":"publisher","first-page":"e246228","DOI":"10.1001\/jamanetworkopen.2024.6228","volume":"7","author":"B Daly","year":"2024","unstructured":"Daly B, Brawley OW, Gospodarowicz MK, et al. Remote monitoring and data collection for decentralized clinical trials. JAMA Netw Open. 2024;7(4):e246228. doi:https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.6228","journal-title":"JAMA Netw Open"},{"key":"2233_CR25","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s40290-024-00518-x","volume":"38","author":"SD Sinha","year":"2024","unstructured":"Sinha SD, Chary Sriramadasu S, Raphael R, et al. Decentralisation in clinical trials and patient centricity: Benefits and challenges. Pharm Med. 2024;38:109\u2013120. doi:https:\/\/doi.org\/10.1007\/s40290-024-00518-x","journal-title":"Pharm Med"},{"issue":"4","key":"2233_CR26","doi-asserted-by":"publisher","first-page":"e419","DOI":"10.1093\/oncolo\/oyad305","volume":"29","author":"R Chow","year":"2024","unstructured":"Chow R, Drkulec H, Im JHB, et al. The use of wearable devices in oncology patients: A systematic review. Oncologist. 2024;29(4):e419\u2013e430. doi:https:\/\/doi.org\/10.1093\/oncolo\/oyad305","journal-title":"Oncologist"},{"issue":"1","key":"2233_CR27","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/cpt.966","volume":"104","author":"ES Izmailova","year":"2018","unstructured":"Izmailova ES, Wagner JA, Perakslis ED. Wearable devices in clinical trials: Hype and hypothesis. Clin Pharmacol Ther. 2018;104(1):42\u201352. doi:https:\/\/doi.org\/10.1002\/cpt.966","journal-title":"Clin Pharmacol Ther"},{"key":"2233_CR28","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1007\/s13311-020-00901-x","volume":"17","author":"CA Artusi","year":"2020","unstructured":"Artusi CA, Imbalzano G, Sturchio A, et al. Implementation of mobile health technologies in clinical trials of movement disorders: Underutilized potential. Neurotherapeutics. 2020;17:1736\u20131746. doi:https:\/\/doi.org\/10.1007\/s13311-020-00901-x","journal-title":"Neurotherapeutics"},{"issue":"6","key":"2233_CR29","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.2196\/mhealth.7689","volume":"5","author":"KA Kessel","year":"2017","unstructured":"Kessel KA, Vogel MM, Kessel C, et al. Mobile health in oncology: A patient survey about app-assisted cancer care. JMIR Mhealth Uhealth. 2017;5(6):e81. doi:https:\/\/doi.org\/10.2196\/mhealth.7689","journal-title":"JMIR Mhealth Uhealth"},{"issue":"6","key":"2233_CR30","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1200\/JCO.2015.63.0830","volume":"34","author":"E Basch","year":"2016","unstructured":"Basch E, Deal AM, Kris MG, et al. Symptom monitoring with patient-reported outcomes during routine cancer treatment: A randomized controlled trial. J Clin Oncol. 2016;34(6):557\u2013565. doi:https:\/\/doi.org\/10.1200\/JCO.2015.63.0830","journal-title":"J Clin Oncol"},{"key":"2233_CR31","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ctrv.2017.11.009","volume":"63","author":"C Coppola","year":"2018","unstructured":"Coppola C, Rienzo A, Piscopo G, et al. Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Cancer Treat Rev. 2018;63:135\u2013143. doi:https:\/\/doi.org\/10.1016\/j.ctrv.2017.11.009","journal-title":"Cancer Treat Rev"},{"issue":"4","key":"2233_CR32","doi-asserted-by":"publisher","first-page":"543","DOI":"10.5603\/CJ.a2019.0001","volume":"28","author":"L Koltowski","year":"2021","unstructured":"Koltowski L, Balsam P, Glowczynska R, Rokicki JK, Peller M, Maksym J, Blicharz L, Maciejewski K, Niedziela M, Opolski G, Grabowski M. Kardia Mobile applicability in clinical practice: A comparison of Kardia Mobile and standard 12-lead electrocardiogram records in 100 consecutive patients of a tertiary cardiovascular care center. Cardiol J. 2021;28(4):543\u2013548. doi: https:\/\/doi.org\/10.5603\/CJ.a2019.0001.","journal-title":"Cardiol J"},{"issue":"1","key":"2233_CR33","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.jelectrocard.2014.10.005","volume":"48","author":"EH Chung","year":"2015","unstructured":"Chung EH, Guise KD. QTC intervals can be assessed with the AliveCor heart monitor in patients on dofetilide for atrial fibrillation. J Electrocardiol. 2015 Jan-Feb;48(1):8\u20139. doi: https:\/\/doi.org\/10.1016\/j.jelectrocard.2014.10.005. Epub 2014 Nov 19. PMID: 25453194.","journal-title":"J Electrocardiol"},{"issue":"4","key":"2233_CR34","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1038\/s41591-025-03507-y","volume":"31","author":"E Basch","year":"2025","unstructured":"Basch E, Schrag D, Jansen J, Henson S, Ginos B, Stover AM, Carr P, Spears PA, Jonsson M, Deal AM, Bennett AV, Thanarajasingam G, Rogak L, Reeve BB, Snyder C, Bruner D, Cella D, Kottschade LA, Perlmutter J, Geoghegan C, Given B, Mazza GL, Miller R, Strasser JF, Zylla DM, Weiss A, Blinder VS, Wolf AP, Dueck AC. Symptom monitoring with electronic patient-reported outcomes during cancer treatment: final results of the PRO-TECT cluster-randomized trial. Nat Med. 2025;31(4):1225\u20131232. doi: https:\/\/doi.org\/10.1038\/s41591-025-03507-y.","journal-title":"Nat Med"},{"key":"2233_CR35","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1007\/s00520-024-08635-8","volume":"32","author":"SM Chow","year":"2024","unstructured":"Chow SM, Tan BK. Effectiveness of mHealth apps on adherence and symptoms to oral anticancer medications: A systematic review and meta-analysis. Support Care Cancer. 2024;32:426. doi:https:\/\/doi.org\/10.1007\/s00520-024-08635-8","journal-title":"Support Care Cancer"},{"key":"2233_CR36","doi-asserted-by":"publisher","first-page":"e2400205","DOI":"10.1200\/CCI-24-00205","volume":"8","author":"PE Heudel","year":"2024","unstructured":"Heudel PE, Ait Ichou M, Favier B, Crochet H, Blay JY. Can Digital Health Improve Therapeutic Compliance in Oncology? JCO Clin Cancer Inform. 2024;8:e2400205. doi: https:\/\/doi.org\/10.1200\/CCI-24-00205","journal-title":"JCO Clin Cancer Inform"},{"issue":"3","key":"2233_CR37","doi-asserted-by":"publisher","first-page":"e110","DOI":"10.2196\/jmir.9157","volume":"20","author":"A Henriksen","year":"2018","unstructured":"Henriksen A, Haugen Mikalsen M, Woldaregay A, et al. Using fitness trackers and smartwatches to measure physical activity in research: Analysis of consumer wrist-worn wearables. J Med Internet Res. 2018;20(3):e110. doi:https:\/\/doi.org\/10.2196\/jmir.9157","journal-title":"J Med Internet Res"},{"key":"2233_CR38","doi-asserted-by":"publisher","first-page":"616242","DOI":"10.3389\/fmedt.2020.616242","volume":"2","author":"A Smith","year":"2020","unstructured":"Smith A, White C, Paterson H, et al. Evaluating the effectiveness of Medisafe app for medication adherence: A clinical trial. Front Med Technol. 2020;2:616242. doi:https:\/\/doi.org\/10.3389\/fmedt.2020.616242","journal-title":"Front Med Technol"},{"issue":"3","key":"2233_CR39","doi-asserted-by":"publisher","first-page":"e243354","DOI":"10.1001\/jamanetworkopen.2024.3354","volume":"7","author":"E Chang","year":"2024","unstructured":"Chang E, Penfold RB, Berkman ND. Patient Characteristics and Telemedicine Use in the US, 2022. JAMA Netw Open. 2024;7(3):e243354. doi:https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.3354","journal-title":"JAMA Netw Open"},{"issue":"2","key":"2233_CR40","doi-asserted-by":"publisher","first-page":"e0264436","DOI":"10.1371\/journal.pone.0264436","volume":"17","author":"AR Taha","year":"2022","unstructured":"Taha AR, Shehadeh M, Alshehhi A, et al. The integration of mHealth technologies in telemedicine during the COVID-19 era: A cross-sectional study. PLoS One. 2022;17(2):e0264436. doi:https:\/\/doi.org\/10.1371\/journal.pone.0264436","journal-title":"PLoS One"},{"key":"2233_CR41","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.jss.2022.04.070","volume":"278","author":"SE Hopkins","year":"2022","unstructured":"Hopkins SE, Vidri RJ, Hill MV, Vijayvergia N, Farma JM. A Virtual Tumor Board Platform: A Way to Enhance Decision-Making for Complex Malignancies. J Surg Res. 2022;278:233\u2013239. doi: https:\/\/doi.org\/10.1016\/j.jss.2022.04.070.","journal-title":"J Surg Res"},{"issue":"10","key":"2233_CR42","doi-asserted-by":"publisher","first-page":"e1603-e1610","DOI":"10.1200\/OP.22.00158","volume":"18","author":"CH Davis","year":"2022","unstructured":"Davis CH, Ho J, Stephenson R, August DA, Gee H, Weiner J, Alexander HR, Pitt HA, Berger AC. Virtual Tumor Board Increases Provider Attendance and Case Presentations. JCO Oncol Pract. 2022;18(10):e1603-e1610. doi: https:\/\/doi.org\/10.1200\/OP.22.00158.","journal-title":"JCO Oncol Pract"},{"key":"2233_CR43","doi-asserted-by":"publisher","first-page":"100117","DOI":"10.1016\/j.sintl.2021.100117","volume":"2","author":"A Haleem","year":"2021","unstructured":"Haleem A, Javaid M, Singh RP, Suman R. Telemedicine for healthcare: Capabilities, features, barriers, and applications. Sens Int. 2021;2:100117. doi: https:\/\/doi.org\/10.1016\/j.sintl.2021.100117.","journal-title":"Sens Int"},{"key":"2233_CR44","doi-asserted-by":"publisher","first-page":"e68434","DOI":"10.2196\/68434","volume":"27","author":"CDA Lamas","year":"2025","unstructured":"Lamas CDA, Santana Alves PG, Nader de Ara\u00fajo L, de Souza Paes AB, Cielo AC, Maciel de Almeida Lopes L, Longo Ara\u00fajo de Melo A, Yokoyama T, Pagani Savastano C, Gobi Scudeller P, Carvalho C, Digital Primary Health Unit HCFMUSP Stud.Telehealth Initiative to Enhance Primary Care Access in Brazil (UBS\u2009+\u2009Digital Project): Multicenter Prospective Study. J Med Internet Res 2025;27:e68434. doi: https:\/\/doi.org\/10.2196\/68434","journal-title":"J Med Internet Res"},{"issue":"4","key":"2233_CR45","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1158\/1078-0432.CCR-20-3758","volume":"27","author":"R Winn","year":"2021","unstructured":"Winn R, Adams M, Brown O, et al. Optimizing the use of telemedicine in oncology care: Postpandemic opportunities. Clin Cancer Res. 2021;27(4):933\u2013936. doi:https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-3758","journal-title":"Clin Cancer Res"},{"issue":"3","key":"2233_CR46","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1001\/jamainternmed.2020.5928","volume":"181","author":"SY Patel","year":"2021","unstructured":"Patel SY, Mehrotra A, Huskamp HA, Uscher-Pines L, Ganguli I, Barnett ML. Trends in outpatient care delivery and telemedicine during the COVID-19 pandemic in the US. JAMA Intern Med. 2021;181(3):388\u2013391. doi:https:\/\/doi.org\/10.1001\/jamainternmed.2020.5928","journal-title":"JAMA Intern Med"},{"issue":"1","key":"2233_CR47","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1186\/s12916-024-03652-0","volume":"22","author":"X Sun","year":"2024","unstructured":"Sun X, Jiang Y, Wang J, Fan S, Fu X, An Z, Zhu X, Wu Y. Effects of a mobile health intervention based on a multitheoretical model of health behavior change on anxiety and depression, fear of cancer progression, and quality of life in patients with differentiated thyroid cancer: A randomized controlled trial. BMC Med. 2024;22(1):466. doi: https:\/\/doi.org\/10.1186\/s12916-024-03652-0.","journal-title":"BMC Med"},{"key":"2233_CR48","doi-asserted-by":"publisher","first-page":"n1647","DOI":"10.1136\/bmj.n1647","volume":"374","author":"R Maguire","year":"2021","unstructured":"Maguire R, McCann L, Kotronoulas G, et al. Real time remote symptom monitoring during chemotherapy for cancer: European multicentre randomised controlled trial (eSMART). BMJ. 2021;374:n1647. doi:https:\/\/doi.org\/10.1136\/bmj.n1647.","journal-title":"BMJ"},{"issue":"4","key":"2233_CR49","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1001\/jamaoncol.2023.6565","volume":"10","author":"C Underhill","year":"2024","unstructured":"Underhill C, Freeman J, Dixon J, et al. Decentralized clinical trials as a new paradigm of trial delivery to improve equity of access. JAMA Oncol. 2024;10(4):526\u2013530. doi:https:\/\/doi.org\/10.1001\/jamaoncol.2023.6565.","journal-title":"JAMA Oncol"},{"issue":"5","key":"2233_CR50","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/oncolo\/oyae016","volume":"29","author":"S Kagalwalla","year":"2024","unstructured":"Kagalwalla S, Tsai AK, George M, Waldock A, Davis S, Jewett P, Vogel RI, Ganguli I, Booth C, Dusetzina SB, Rocque GB, Blaes AH, Gupta A. Consuming Patients\u2019 Days: Time Spent on Ambulatory Appointments by People With Cancer. Oncologist. 2024;29(5):400\u2013406. doi: https:\/\/doi.org\/10.1093\/oncolo\/oyae016.","journal-title":"Oncologist"},{"key":"2233_CR51","doi-asserted-by":"publisher","first-page":"769","DOI":"10.5858\/arpa.2019-0139-OA","volume":"144","author":"V Le","year":"2020","unstructured":"Le V, Wagar EA, Phipps RA, et al. Improving patient experience of wait times and courtesy through electronic sign-in and notification in the phlebotomy clinic. Arch Pathol Lab Med. 2020;144:769\u2013775","journal-title":"Arch Pathol Lab Med"},{"key":"2233_CR52","doi-asserted-by":"publisher","first-page":"E151","DOI":"10.1002\/lary.28020","volume":"130","author":"N Silver","year":"2020","unstructured":"Silver N, Weber RS, Lozano M, et al. Reducing patient wait times in a head and neck cancer outpatient clinic: A pilot study. Laryngoscope. 2020;130:E151\u2013E154","journal-title":"Laryngoscope"},{"issue":"1","key":"2233_CR53","doi-asserted-by":"publisher","first-page":"20613","DOI":"10.1038\/s41598-022-24330-2","volume":"12","author":"F Zouari","year":"2022","unstructured":"Zouari F, Oon WY, Modak D, Lee WH, Kwok WC, Cao P, Lee WN, Tam TCC, Wong EC, Chan RW. Affordable, portable and self-administrable electrical impedance tomography enables global and regional lung function assessment. Sci Rep. 2022;12(1):20613. doi: https:\/\/doi.org\/10.1038\/s41598-022-24330-2.","journal-title":"Sci Rep"},{"issue":"18","key":"2233_CR54","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.3390\/diagnostics14182037","volume":"14","author":"G Lippi","year":"2024","unstructured":"Lippi G, Pighi L, Mattiuzzi C. Update on Patient Self-Testing with Portable and Wearable Devices: Advantages and Limitations. Diagnostics (Basel). 2024;14(18):2037. doi: https:\/\/doi.org\/10.3390\/diagnostics14182037.","journal-title":"Diagnostics (Basel)"},{"issue":"4","key":"2233_CR55","doi-asserted-by":"publisher","first-page":"e000853","DOI":"10.1136\/esmoopen-2020-000853","volume":"5","author":"CE Onesti","year":"2020","unstructured":"Onesti CE, Rugo HS, Generali D, et al. Oncological care organisation during COVID-19 outbreak. ESMO Open. 2020;5(4):e000853. doi:https:\/\/doi.org\/10.1136\/esmoopen-2020-000853","journal-title":"ESMO Open"},{"issue":"11","key":"2233_CR56","doi-asserted-by":"publisher","first-page":"e2445363","DOI":"10.1001\/jamanetworkopen.2024.45363","volume":"7","author":"SD Doshi","year":"2024","unstructured":"Doshi SD, Charvadeh YK, Seier K, et al. Perspectives on Telemedicine Visits Reported by Patients With Cancer. JAMA Netw Open. 2024;7(11):e2445363. doi:https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.45363","journal-title":"JAMA Netw Open"},{"issue":"1","key":"2233_CR57","doi-asserted-by":"publisher","first-page":"e2250211","DOI":"10.1001\/jamanetworkopen.2022.50211","volume":"6","author":"KB Patel","year":"2023","unstructured":"Patel KB, Turner K, Alishahi Tabriz A, et al. Estimated indirect cost savings of using telehealth among nonelderly patients with cancer. JAMA Netw Open. 2023;6(1):e2250211. doi:https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.50211","journal-title":"JAMA Netw Open"},{"issue":"12","key":"2233_CR58","doi-asserted-by":"publisher","first-page":"e26381","DOI":"10.2196\/26381","volume":"23","author":"M Were","year":"2021","unstructured":"Were M, Savai S, Mokaya B, et al. mUzima mobile electronic health record (EHR) system: Development and implementation at scale. J Med Internet Res. 2021;23(12):e26381. doi:https:\/\/doi.org\/10.2196\/26381","journal-title":"J Med Internet Res"},{"key":"2233_CR59","doi-asserted-by":"publisher","unstructured":"Rajasimha, H. (2024). The Advent of Patient-Centric Technologies to Combat the High Dropout Rates: Revolutionizing Clinical Trials: Combating Attrition in Clinical Trials: Embracing a Patient-Centric Approach Through Innovative Technologies. Telehealth and Medicine Today, 9(2). https:\/\/doi.org\/10.30953\/thmt.v9.474","DOI":"10.30953\/thmt.v9.474"},{"issue":"5","key":"2233_CR60","doi-asserted-by":"publisher","first-page":"3857","DOI":"10.3390\/curroncol28050329","volume":"28","author":"S Sundquist","year":"2021","unstructured":"Sundquist S, Batist G, Brodeur-Robb K, Dyck K, Eigl BJ, Lee DK, Limoges J, Longstaff H, Pankovich J, Sadura A, Sullivan P, Dancey JE. CRAFT-A Proposed Framework for Decentralized Clinical Trials Participation in Canada. Curr Oncol. 2021;28(5):3857\u20133865. doi: https:\/\/doi.org\/10.3390\/curroncol28050329.","journal-title":"Curr Oncol"},{"key":"2233_CR61","doi-asserted-by":"publisher","unstructured":"Lu X, Yang C, Liang L, Hu G, Zhong Z, Jiang Z. Artificial intelligence for optimizing recruitment and retention in clinical trials: a scoping review. J Am Med Inform Assoc. 2024;31(11):2749\u20132759. doi: 10.1093\/jamia\/ocae243. Erratum in: J Am Med Inform Assoc. 2025;32(1):260. doi: https:\/\/doi.org\/10.1093\/jamia\/ocae283","DOI":"10.1093\/jamia\/ocae283"},{"issue":"4","key":"2233_CR62","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1111\/ajr.12104","volume":"22","author":"S Sabesan","year":"2014","unstructured":"Sabesan S, Kelly J, Evans R, et al. Telemedicine for rural cancer care in North Queensland: Bringing cancer care home. Aust J Rural Health. 2014;22(4):214\u2013218. doi:https:\/\/doi.org\/10.1111\/ajr.12104","journal-title":"Aust J Rural Health"},{"issue":"28_suppl","key":"2233_CR63","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1200\/JCO.2022.40.28_suppl.418","volume":"40","author":"JN Dionne-Odom","year":"2022","unstructured":"Dionne-Odom JN, Currie ER, Johnston EE, et al. Feasibility of a mobile health pain and symptom support intervention for cancer patients. J Clin Oncol. 2022;40(28_suppl):418. doi:https:\/\/doi.org\/10.1200\/JCO.2022.40.28_suppl.418","journal-title":"J Clin Oncol"},{"issue":"2","key":"2233_CR64","doi-asserted-by":"publisher","first-page":"e29922","DOI":"10.2196\/29922","volume":"6","author":"A Martinez-Millana","year":"2022","unstructured":"Martinez-Millana A, Fico G, et al. Evaluating mHealth apps for chronic disease management in underserved communities. JMIR Form Res. 2022;6(2):e29922. doi:https:\/\/doi.org\/10.2196\/29922","journal-title":"JMIR Form Res"},{"key":"2233_CR65","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(20)30311-4","author":"AB Labrique","year":"2023","unstructured":"Labrique AB, Vasudevan L, et al. mHealth interventions in low- and middle-income countries: A systematic review. Lancet Glob Health. 2023;[Epub ahead of print]. doi:https:\/\/doi.org\/10.1016\/S2214-109X(20)30311-4","journal-title":"Lancet Glob Health"},{"issue":"4","key":"2233_CR66","doi-asserted-by":"publisher","first-page":"e10256","DOI":"10.2196\/10256","volume":"21","author":"WL Tarver","year":"2019","unstructured":"Tarver WL, Haggstrom DA. The Use of Cancer-Specific Patient-Centered Technologies Among Underserved Populations in the United States: Systematic Review. J Med Internet Res. 2019;21(4):e10256. doi: https:\/\/doi.org\/10.2196\/10256.","journal-title":"J Med Internet Res"},{"issue":"5","key":"2233_CR67","doi-asserted-by":"publisher","first-page":"e316","DOI":"10.1016\/S2589-7500(23)00049-3","volume":"5","author":"KM Shaffer","year":"2023","unstructured":"Shaffer KM, Turner KL, Siwik C, et al. Digital health and telehealth in cancer care: A scoping review of reviews. Lancet Digit Health. 2023;5(5):e316\u2013e327. doi:https:\/\/doi.org\/10.1016\/S2589-7500(23)00049-3","journal-title":"Lancet Digit Health"},{"issue":"1","key":"2233_CR68","doi-asserted-by":"publisher","first-page":"2","DOI":"10.3390\/informatics11010002","volume":"11","author":"I Machorro-Cano","year":"2024","unstructured":"Machorro-Cano I, Olmedo-Aguirre JO, Alor-Hern\u00e1ndez G, et al. Cloud-based platforms for health monitoring: A review. Informatics. 2024;11(1):2. doi:https:\/\/doi.org\/10.3390\/informatics11010002","journal-title":"Informatics"},{"key":"2233_CR69","unstructured":"WEF Intelligent Clinical Trials Report. Available from: https:\/\/reports.weforum.org\/docs\/WEF_Intelligent_Clinical_Trials_2024.pdf"},{"key":"2233_CR70","doi-asserted-by":"publisher","first-page":"n1248","DOI":"10.1136\/bmj.n1248","volume":"373","author":"G Tangari","year":"2021","unstructured":"Tangari G, Ikram M, Ijaz K, Kaafar MA, Berkovsky S. Mobile health and privacy: cross sectional study. BMJ. 2021;373:n1248. doi: https:\/\/doi.org\/10.1136\/bmj.n1248.","journal-title":"BMJ"},{"issue":"2","key":"2233_CR71","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1002\/cpt.2628","volume":"112","author":"AJ de Jong","year":"2022","unstructured":"de Jong AJ, van Rijssel TI, Zuidgeest MGP, et al. Opportunities and challenges for decentralized clinical trials: European regulators\u2019 perspective. Clin Pharmacol Ther. 2022;112(2):344\u2013352. doi:https:\/\/doi.org\/10.1002\/cpt.2628","journal-title":"Clin Pharmacol Ther"},{"key":"2233_CR72","doi-asserted-by":"publisher","first-page":"106219","DOI":"10.1016\/j.cct.2020.106219","volume":"100","author":"C Rosa","year":"2021","unstructured":"Rosa C, Marsch LA, Winstanley EL, Brunner M, Campbell ANC. Using digital technologies in clinical trials: Current and future applications. Contemp Clin Trials. 2021;100:106219. doi:https:\/\/doi.org\/10.1016\/j.cct.2020.106219","journal-title":"Contemp Clin Trials"},{"key":"2233_CR73","unstructured":"FDA. Evolving role of decentralized clinical trials and digital health technologies. Available from: https:\/\/www.fda.gov\/drugs\/cder-conversations\/evolving-role-decentralized-clinical-trials-and-digital-health-technologies?utm_source=chatgpt.com"},{"key":"2233_CR74","unstructured":"European Union. (2016). General Data Protection Regulation (GDPR). Regulation (EU) 2016\/679."},{"key":"2233_CR75","unstructured":"U.S. Department of Health & Human Services. (1996). Health Insurance Portability and Accountability Act (HIPAA)."},{"key":"2233_CR76","unstructured":"U.S. Food and Drug Administration (FDA). (2023). Digital Health Technologies for Remote Data Acquisition in Clinical Investigations. https:\/\/www.fda.gov\/regulatory-information\/search-fda-guidance-documents\/digital-health-technologies-remote-data-acquisition-clinical-investigations"},{"key":"2233_CR77","unstructured":"European Medicines Agency (EMA). (2023). Guideline on Computerised Systems and Electronic Data in Clinical Trials. https:\/\/www.ema.europa.eu\/en\/documents\/regulatory-procedural-guideline\/guideline-computerised-systems-and-electronic-data-clinical-trials_en.pdf"},{"issue":"1","key":"2233_CR78","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41746-022-00573-1","volume":"5","author":"A Ess\u00e9n","year":"2022","unstructured":"Ess\u00e9n A, Stern AD, Haase CB, et al. Health app policy: International comparison of nine countries\u2019 approaches. NPJ Digit Med. 2022;5(1):31. doi:https:\/\/doi.org\/10.1038\/s41746-022-00573-1","journal-title":"NPJ Digit Med"},{"key":"2233_CR79","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/s41746-024-01205-6","volume":"7","author":"T Lalova-Spinks","year":"2024","unstructured":"Lalova-Spinks T, Valcke P, Ioannidis JPA, et al. EU-US data transfers: An enduring challenge for health research collaborations. NPJ Digit Med. 2024;7:215. doi:https:\/\/doi.org\/10.1038\/s41746-024-01205-6","journal-title":"NPJ Digit Med"},{"key":"2233_CR80","doi-asserted-by":"publisher","first-page":"e43883","DOI":"10.2196\/43883","volume":"25","author":"E Cohen","year":"2023","unstructured":"Cohen E, Byrom B, Becher A, et al. Comparative effectiveness of eConsent: Systematic review. J Med Internet Res. 2023;25:e43883. doi:https:\/\/doi.org\/10.2196\/43883","journal-title":"J Med Internet Res"},{"issue":"4","key":"2233_CR81","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/jamia\/ocac198","volume":"30","author":"R Hussein","year":"2023","unstructured":"Hussein R, Griffin AC, Pichon A, Oldenburg J. A guiding framework for creating a comprehensive strategy for mHealth data sharing, privacy, and governance in low- and middle-income countries. J Am Med Inform Assoc. 2023;30(4):787\u2013794. doi:https:\/\/doi.org\/10.1093\/jamia\/ocac198","journal-title":"J Am Med Inform Assoc"},{"issue":"4","key":"2233_CR82","doi-asserted-by":"publisher","first-page":"e26297","DOI":"10.1016\/j.heliyon.2024.e26297","volume":"10","author":"C Mennella","year":"2024","unstructured":"Mennella C, Maniscalco U, De Pietro G, Esposito M. Ethical and regulatory challenges of AI technologies in healthcare: A narrative review. Heliyon. 2024;10(4):e26297. doi: https:\/\/doi.org\/10.1016\/j.heliyon.2024.e26297.","journal-title":"Heliyon"},{"issue":"5","key":"2233_CR83","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1158\/2159-8290.CD-23-1199","volume":"14","author":"W Lotter","year":"2024","unstructured":"Lotter W, Hassett MJ, Schultz N, et al. Artificial intelligence in oncology: Current landscape, challenges, and future directions. Cancer Discov. 2024;14(5):711\u2013726. doi:https:\/\/doi.org\/10.1158\/2159-8290.CD-23-1199","journal-title":"Cancer Discov"},{"issue":"1","key":"2233_CR84","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1208\/s12248-021-00644-3","volume":"24","author":"S Kolluri","year":"2022","unstructured":"Kolluri S, Lin J, Liu R, Zhang Y, Zhang W. Machine learning and artificial intelligence in pharmaceutical research and development: A review. AAPS J. 2022;24(1):19. doi:https:\/\/doi.org\/10.1208\/s12248-021-00644-3","journal-title":"AAPS J"},{"issue":"4","key":"2233_CR85","doi-asserted-by":"publisher","first-page":"e11949","DOI":"10.2196\/11949","volume":"6","author":"DM Maslove","year":"2018","unstructured":"Maslove DM, Klein J, Brohman K, Martin P. Using blockchain technology to manage clinical trials data: A proof-of-concept study. JMIR Med Inform. 2018;6(4):e11949. doi:https:\/\/doi.org\/10.2196\/11949","journal-title":"JMIR Med Inform"},{"key":"2233_CR86","unstructured":"Zhuang Y, Sheets LR, Shae Z, et al. Applying blockchain technology to enhance clinical trial recruitment. AMIA Annu Symp Proc. 2020;2019:1276\u20131285"},{"key":"2233_CR87","doi-asserted-by":"publisher","first-page":"e44316","DOI":"10.2196\/44316","volume":"11","author":"J Scheer","year":"2023","unstructured":"Scheer J, Areias AC, Molinos M, et al. Engagement and utilization of a complete remote digital care program for musculoskeletal pain management in urban and rural areas across the United States: Longitudinal cohort study. JMIR Mhealth Uhealth. 2023;11:e44316. doi:https:\/\/doi.org\/10.2196\/44316","journal-title":"JMIR Mhealth Uhealth"},{"key":"2233_CR88","doi-asserted-by":"publisher","first-page":"104977","DOI":"10.1016\/j.ejmg.2024.104977","volume":"72","author":"FH Chen","year":"2024","unstructured":"Chen FH, Hartman AL, Letinturier MCV, et al. Telehealth for rare disease care, research, and education across the globe: A review of the literature by the IRDiRC telehealth task force. Eur J Med Genet. 2024;72:104977. doi:https:\/\/doi.org\/10.1016\/j.ejmg.2024.104977","journal-title":"Eur J Med Genet"},{"issue":"7","key":"2233_CR89","doi-asserted-by":"publisher","first-page":"e17508","DOI":"10.2196\/17508","volume":"22","author":"L Ismail","year":"2020","unstructured":"Ismail L, Materwala H, Karduck AP, Adem A. Requirements of health data management systems for biomedical care and research: A scoping review. J Med Internet Res. 2020;22(7):e17508. doi:https:\/\/doi.org\/10.2196\/17508","journal-title":"J Med Internet Res"},{"issue":"4","key":"2233_CR90","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1002\/ajmg.a.63109","volume":"191","author":"N Falah","year":"2023","unstructured":"Falah N, Terry A, Umer A, et al. A pilot study of home-based genetic testing completion rate in telegenetics cancer clinics in West Virginia Appalachia. Am J Med Genet A. 2023;191(4):1013\u20131019. doi:https:\/\/doi.org\/10.1002\/ajmg.a.63109","journal-title":"Am J Med Genet A"},{"issue":"23","key":"2233_CR91","doi-asserted-by":"publisher","first-page":"3919","DOI":"10.3390\/cancers16233919","volume":"16","author":"CM Tegeler","year":"2024","unstructured":"Tegeler CM, Hartkopf AD, Banys-Paluchowski M, et al. Circulating tumor DNA in early and metastatic breast cancer: Current role and what is coming next. Cancers (Basel). 2024;16(23):3919. doi:https:\/\/doi.org\/10.3390\/cancers16233919","journal-title":"Cancers (Basel)"},{"key":"2233_CR92","unstructured":"https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04862143"},{"key":"2233_CR93","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/s41746-024-01214-5","volume":"7","author":"A Valachis","year":"2024","unstructured":"Valachis, A., Lindman, H. Lessons learned from an unsuccessful decentralized clinical trial in Oncology. npj Digit. Med. 7, 211 (2024). https:\/\/doi.org\/10.1038\/s41746-024-01214-5","journal-title":"npj Digit. Med."},{"issue":"3","key":"2233_CR94","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1080\/17576180.2025.2452774","volume":"17","author":"V Leiva","year":"2025","unstructured":"Leiva V, Castro C. Artificial intelligence and blockchain in clinical trials: Enhancing data governance efficiency, integrity, and transparency. Bioanalysis. 2025;17(3):161\u2013176. doi:https:\/\/doi.org\/10.1080\/17576180.2025.2452774","journal-title":"Bioanalysis"}],"container-title":["Journal of Medical Systems"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-025-02233-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10916-025-02233-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10916-025-02233-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T17:48:03Z","timestamp":1757353683000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10916-025-02233-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2233"],"URL":"https:\/\/doi.org\/10.1007\/s10916-025-02233-9","relation":{},"ISSN":["1573-689X"],"issn-type":[{"value":"1573-689X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"31 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval\u00a0<!--Emphasis Type='Bold' removed-->and permission to participate"}},{"value":"We, the authors, hereby grant permission for the publication of this manuscript in\u00a0Journal of Medical Systems.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors\u2019 Information (optional)Human Studies and Informed Consent"}},{"value":"We confirm that our study is not a clinical trial. \u201cClinical trial number: not applicable.\u201d","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Registration"}},{"value":"ChatGPT was used for language editing only. The content and overall flow of the manuscript were entirely developed by the authors.\u201d","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Using AI"}},{"value":"The authors declare no competing interests.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"103"}}